Unmasking Game Changing Insights on GLP-1 & GIP/GLP-1

Solutions

DrugVoice unlocks the authentic voice of Healthcare Professionals and Patients

Find Out More Button

PeopleVoice turns unstructured Employee data into strategic intelligence

Find Out More Button

DrugVoice

PeopleVoice

About Us

TMLabs is our in-house Centre of Excellence for Data Science for Life Sciences – where we train, test, and refine proprietary models purpose-built to decode real-world health dialogue at scale

About Us Button

Articles & Scientific Publications

Our Articles & Scientific Publications showcase the rigorous methodologies and validated outcomes behind our Data Science – demonstrating the impact of Talking Medicines Predictive Intelligence in peer-reviewed research

See Publications Button

About TMLabs

Scientific Publications

Resources

Blogs

Our Blogs share insights at the intersection of data science, life sciences, and real-world health, covering trends, thought leadership, and innovation from the TM team

The Talking Room

Discover how The Talking Room demystifies AI, LLMs, and Machine Learning, showcasing data stories and expert insights that transform Patient and HCP conversations into actionable intelligence

Compliance Hub

The Compliance Hub outlines our commitment to data integrity, ethical AI, and regulatory standards, ensuring our intelligence is accurate, safe, and fully compliant

ESG

Our ESG principles guide how we operate, driving responsible innovation, and reducing environmental impact through ethical operating and data practices

Elevating Healthcare Strategy: Unmasking Game-Changing Insights on GLP-1 & GIP/GLP-1 with Drug-GPT Technology

In collaboration with our partners at Sermo, our Advanced Data Science and Artificial Intelligence solutions played a crucial role in uncovering previously unseen intelligence about GLP-1 and GIP/GLP-1. This report is designed to comprehend challenges, perceptions, attitudes, and usage surrounding GLP-1 and GIP/GLP-1 medications among patients and physicians, reflecting not just our efforts but the collaborative success in providing valuable healthcare intelligence to our partners.

Gain exclusive access to this report and uncover previously unseen insights into the impact of GLP-1 and GIP/GLP-1 drugs in the type 2 diabetes space.

Gain insight into how GLP-1 and GIP/GLP-1 drugs have revolutionized the type 2 diabetes space.
Explore how physicians and patients alike are talking, thinking, and reacting to GLP-1 and GIP/GLP-1 medications.
Deep dive into learnings about specific medications like semaglutide and tirzepatide both from the physician and patient perspective.

Download Now

Sign Up to Stay Ahead of Message Impact

Discover how Pharma marketeers are finally measuring which messages change HCP behavior. Our newsletter shares evidence-led insights powered by DrugVoice and the Message Resonance Score™ so you can predict and prove message impact—before prescriptions are written.

Subscribe on LinkedIn